AMA Home Online Series Home Course Home References Print Course
CME Information
Introduction
Nonpharmacologic Management Options
Guidelines for Treatment
Pharmacologic Prevention and Treatment of Osteoporosis
Antiresorptive Therapy: Bisphosphonates
Antiresorptive Therapy: Hormone Therapy
Antiresorptive Therapy: Selective Estrogen Receptor Modulators
Antiresorptive Therapy: Calcitonin
Anabolic Therapy: Teriparatide
Combination Therapy
Monitoring Therapy
Summary
Self-Assessment
left_shadow

   Antiresorptive Therapy: Calcitonin

02 of 02
 

Analgesic Effect of Calcitonin
Calcitonin is also thought to have an analgesic effect on bone pain associated with vertebral fractures. For this reason, calcitonin is often used to treat the pain associated with acute vertebral fragility fractures. For example, the Guidelines on Glucocorticoid-induced Osteoporosis published by the American College of Rheumatology, suggest the use of calcitonin as an analgesic in patients with osteoporotic fracture (e.g., a vertebral fracture), whose pain is not relieved with simple analgesics. The guidelines recommend treatment until the pain is controlled, followed by tapering of the medication over 4-6 weeks.

 
left_shadow

 

02 of 02

Copyright 1995-2006 American Medical Association. All rights reserved.